TGF-β and Diabetic Nephropathy: Lessons Learned Over the Past 20 Years.
作者信息
Gewin Leslie S
机构信息
Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center (VUMC), Nashville, Tennessee; Department of Medicine, Veterans Affairs Hospital, Tennessee Valley Healthcare System, Nashville, Tennessee; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee.
出版信息
Am J Med Sci. 2020 Feb;359(2):70-72. doi: 10.1016/j.amjms.2019.11.010. Epub 2019 Nov 29.
Abstract
摘要
相似文献
1
TGF-β and Diabetic Nephropathy: Lessons Learned Over the Past 20 Years.转化生长因子-β与糖尿病肾病：过去20年的经验教训
Am J Med Sci. 2020 Feb;359(2):70-72. doi: 10.1016/j.amjms.2019.11.010. Epub 2019 Nov 29.
2
Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.转化生长因子-β1 介导的肾纤维化依赖于 let-7b 对转化生长因子受体 1 表达的调节。
Kidney Int. 2014 Feb;85(2):352-61. doi: 10.1038/ki.2013.372. Epub 2013 Oct 2.
3
Protective effects of calcitriol on diabetic nephropathy are mediated by down regulation of TGF-β1 and CIP4 in diabetic nephropathy rat.骨化三醇对糖尿病肾病的保护作用是通过下调糖尿病肾病大鼠的转化生长因子-β1和CIP4来介导的。
Int J Clin Exp Pathol. 2015 Apr 1;8(4):3503-12. eCollection 2015.
4
Transforming growth factor-β1 and diabetic nephropathy.转化生长因子-β1与糖尿病肾病
Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F689-F696. doi: 10.1152/ajprenal.00502.2015. Epub 2015 Dec 30.
5
Effects of vitamin D on renal fibrosis in diabetic nephropathy model rats.维生素D对糖尿病肾病模型大鼠肾纤维化的影响。
Int J Clin Exp Pathol. 2014 May 15;7(6):3028-37. eCollection 2014.
6
Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.黄芪甲苷对糖尿病KKAy小鼠肾组织中转化生长因子-β1、SMAD2/3和α-平滑肌肌动蛋白表达的影响
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6828-34. eCollection 2015.
7
Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice.阻断 KCa3.1 通过 TGF-β1/Smad 通路减轻糖尿病小鼠的肾纤维化。
Diabetes. 2013 Aug;62(8):2923-34. doi: 10.2337/db13-0135. Epub 2013 May 8.
8
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.西格列汀通过阻断 TGF-β1/Smad 信号通路改善糖尿病肾病。
Int J Mol Med. 2018 May;41(5):2784-2792. doi: 10.3892/ijmm.2018.3504. Epub 2018 Feb 16.
9
Effect of catalpol on diabetic nephropathy in rats.梓醇对大鼠糖尿病肾病的影响。
Phytomedicine. 2013 Aug 15;20(11):1023-9. doi: 10.1016/j.phymed.2013.04.007. Epub 2013 Jun 5.
10
Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.紫草素通过抑制 TGF-β1/Smad 通路改善糖尿病小鼠的肾功能障碍和纤维化。
Hum Cell. 2018 Jul;31(3):199-209. doi: 10.1007/s13577-017-0192-8. Epub 2018 Mar 17.
引用本文的文献
1
Identification of Differentially Expressed Genes and Pathways in Non-Diabetic CKD and Diabetic CKD by Integrated Human Transcriptomic Bioinformatics Analysis.通过整合人类转录组生物信息学分析鉴定非糖尿病性慢性肾脏病和糖尿病性慢性肾脏病中差异表达的基因和通路
Int J Mol Sci. 2025 Aug 1;26(15):7421. doi: 10.3390/ijms26157421.
2
Impact of baicalin and components of Scutellaria baicalensis on renal fibrosis of diabetic kidney disease.黄芩苷及黄芩成分对糖尿病肾病肾纤维化的影响
Front Pharmacol. 2024 Dec 6;15:1480626. doi: 10.3389/fphar.2024.1480626. eCollection 2024.
3
O-linked β-N-acetylglucosamine (O-GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy.O-连接的β-N-乙酰葡糖胺（O-GlcNAc）修饰：糖尿病肾病新出现的发病机制及治疗靶点
Diabet Med. 2025 Feb;42(2):e15436. doi: 10.1111/dme.15436. Epub 2024 Sep 16.
4
Exercise training improves diabetic renal injury by reducing fetuin-A, oxidative stress and inflammation in type 2 diabetic rats.运动训练通过降低2型糖尿病大鼠的胎球蛋白-A、氧化应激和炎症来改善糖尿病肾损伤。
Heliyon. 2024 Mar 12;10(6):e27749. doi: 10.1016/j.heliyon.2024.e27749. eCollection 2024 Mar 30.
5
Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment.阿哌巴酮可下调肾系膜细胞和肾功能损害患者的纤维化、炎症和钙化过程。
Biomedicines. 2023 Jun 8;11(6):1663. doi: 10.3390/biomedicines11061663.
6
Nano-Technological Approaches for Targeting Kidney Diseases With Focus on Diabetic Nephropathy: Recent Progress, and Future Perspectives.聚焦糖尿病肾病的靶向治疗肾脏疾病的纳米技术方法：最新进展与未来展望
Front Bioeng Biotechnol. 2022 May 13;10:870049. doi: 10.3389/fbioe.2022.870049. eCollection 2022.
7
Troxerutin affects nephropathy signaling events in the kidney of type-1 diabetic male rats.曲克芦丁影响1型糖尿病雄性大鼠肾脏中的肾病信号转导事件。
Avicenna J Phytomed. 2022 Mar-Apr;12(2):109-115. doi: 10.22038/AJP.2021.18875.
8
TGF-β1 is involved in senescence-related pathways in glomerular endothelial cells via p16 translocation and p21 induction.TGF-β1 通过 p16 易位和 p21 诱导参与肾小球内皮细胞衰老相关途径。
Sci Rep. 2021 Nov 4;11(1):21643. doi: 10.1038/s41598-021-01150-4.
9
The 100 top-cited articles in diabetic kidney disease: a bibliometric analysis.100 篇高被引糖尿病肾病文献的计量分析。
Ren Fail. 2021 Dec;43(1):781-795. doi: 10.1080/0886022X.2021.1919528.
10
Upregulation of miRNA-1228-3p alleviates TGF-β-induced fibrosis in renal tubular epithelial cells.miRNA-1228-3p 的上调缓解了 TGF-β诱导的肾小管上皮细胞纤维化。
Histol Histopathol. 2020 Oct;35(10):1125-1133. doi: 10.14670/HH-18-242. Epub 2020 Jul 28.
本文引用的文献
1
Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy.Smad3 缺失可预防 2 型糖尿病肾病中的肾纤维化和炎症。
Metabolism. 2020 Feb;103:154013. doi: 10.1016/j.metabol.2019.154013. Epub 2019 Nov 15.
2
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.卡格列净与 2 型糖尿病和肾病患者的肾脏结局。
N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.
3
Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.血小板反应蛋白-1 对潜伏转化生长因子-β的激活调控：纤维化疾病的治疗靶点。
Matrix Biol. 2018 Aug;68-69:28-43. doi: 10.1016/j.matbio.2017.12.009. Epub 2017 Dec 27.
4
Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy.基质金属蛋白酶-2的两种不同亚型在实验性和人类糖尿病肾病中的表达增强。
PLoS One. 2017 Feb 8;12(2):e0171625. doi: 10.1371/journal.pone.0171625. eCollection 2017.
5
Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications.关于适应性不良的己糖胺生物合成和O-连接的N-乙酰葡糖胺化在糖尿病心脏并发症发生发展中的作用的见解。
Pharmacol Res. 2017 Feb;116:45-56. doi: 10.1016/j.phrs.2016.12.016. Epub 2016 Dec 14.
6
Anti-TGF-1 Antibody Therapy in Patients with Diabetic Nephropathy.抗转化生长因子-1抗体疗法治疗糖尿病肾病患者
J Am Soc Nephrol. 2017 Mar;28(3):953-962. doi: 10.1681/ASN.2015111230. Epub 2016 Sep 19.
7
Transforming growth factor-β1 and diabetic nephropathy.转化生长因子-β1与糖尿病肾病
Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F689-F696. doi: 10.1152/ajprenal.00502.2015. Epub 2015 Dec 30.
8
Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease.蜗牛 1 诱导的部分上皮-间充质转化导致小鼠肾纤维化，并且可以作为靶点逆转已建立的疾病。
Nat Med. 2015 Sep;21(9):989-97. doi: 10.1038/nm.3901. Epub 2015 Aug 3.
9
Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice.低水平的转化生长因子β1表达可预防小鼠糖尿病肾病，而高水平表达则会加重该病。
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5815-20. doi: 10.1073/pnas.1504777112. Epub 2015 Apr 20.
10
MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator.基质金属蛋白酶-9和N-甲基-D-天冬氨酸受体介导的糖尿病性肾血管重塑及肾功能障碍机制：硫化氢是关键调节因子。
Nitric Oxide. 2015 Apr 30;46:172-85. doi: 10.1016/j.niox.2015.02.003. Epub 2015 Feb 7.
Zotero 插件